Medical insurance reimbursement of mesenchymal stem cells

Mesenchymal stem cell treatment insurance liability The insured suffers from non-hereditary and non-congenital malignant hematological diseases, is hospitalized in a designated hospital and receives umbilical cord blood stem cell transplantation treatment, and then uses umbilical cord blood mesenchymal stem cells for adjuvant treatment, which meets the basic medical expenses and necessary and reasonable hospitalization medical expenses in medical insurance coverage stipulated by the local social medical insurance department. After deducting the deductible 100 yuan and the third party (social security, new rural cooperative medical system, other insurance companies, etc.) to pay in advance. ), the insurance company will pay 80% of the insurance premium for umbilical cord blood stem cell transplantation, with a maximum payment of 300,000 yuan.